Abstract
Skin adnexal neoplasms comprise a wide spectrum of more than 80 benign and malignant tumours, exhibiting morphological differentiation towards pilosebaceous unit, eccrine and apocrine glands. In addition more than one line of differentiation in this neoplasm could be observed. These tumours generally exhibit a benign behaviour, but malignant histotypes also exist. Clinical diagnosis of specific entity and of their potential malignancy is quite impossible. Thus, the diagnosis always requires surgical excision of skin lesion, and histological features at haematoxylin and eosin-stained sections are considered generally adequate for the correct classification of skin adnexal tumours. The use of histochemical and immunohistochemical stains could further aid in this purpose. Finally, they are usually encountered as single, sporadic tumours, but they may also occasionally be multiple and hereditary, heralding complex genetic syndromes that comprise visceral cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rodriguez-Diaz E, Armio M. Mixed tumors with follicular differentiation: complex neoplasms of the primary epithelial germ. Int J Dermatol. 1994;34:782–5.
Winship I, Dudding T. Lessons from the skin-cutaneous features of familial cancer. Lancet Oncol. 2008;9:462–72.
Kanitakis J. Adnexal tumors of the skin as markers of cancer-prone syndrome. J Eur Acad Dermatol Venereol. 2010;24:379–87.
Klein W, Chan E, Seykora JT. Tumors of the epidermal appendages. In: Elder DE, editor. Lever’s histopathology of the skin. 9th ed. Philadelphia: Lippincott Williams & Wilikins; 2005. p. 867–926.
Weedon D. Tumors of cutaneous appendages. In: Weedon D, editor. Skin pathology. 2nd ed. Edinburgh: Churchill Livingstone; 2002. p. 859–916.
Alsaad KO, Obaidat NA, Ghazarian D. Skin adnexal neoplasms—part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol. 2007;60:129–44.
Yoshida Y, Urabe K, Mashino T, et al. Basal cell carcinomas in association with basaloid follicular hamartoma. Dermatology. 2003;207:57–60.
Akasaka T, Kon S, Mihm Jr MC. Multiple basaloid cell hamartoma with alopecia and autoimmune disease (systemic lupus erythematosus). J Dermatol. 1996;23:821–4.
Morton S, Stevens A, Powell RJ. Basaloid follicular hamartoma, total body hair loss and SLE. Lupus. 1998;3:207–9.
Jih DM, Shapiro M, James WD, et al. Familial basaloid follicular hamartoma: lesional characterization and review of the literature. Am J Dermatopathol. 2003;25:130–7.
Stern JB, Stout DA. Trichofolliculoma showing perineural invasion. Trichofolliculocarcinoma? Arch Dermatol. 1979;115:1003–4.
Plewig G. Sebaceous trichofolliculoma. J Cutan Pathol. 1980;7:394–403.
Ramdial PK, Chrystal V, Madaree A. Folliculose baceous cystic hamartoma. Pathology. 1998;30:212–4.
Welsch MJ, Krunic A, Medenica MM. Birt-Hogg-Dube syndrome. Int J Dermatol. 2005;44:668–73.
Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;6:980–7.
Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceous: a study of 596 cases. J Am Acad Dermatol. 2000;42:263–8.
Xin H, Matt D, Qin JZ, et al. The sebaceous nevus: a nevus with deletions of the PTCH gene. Cancer Res. 1999;59:1834–6.
Harada H, Hashimoto K, Ko MS. The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol. 1996;107:41–3.
Zhang XJ, Liang YH, He PP, et al. Identification of the cylindromatosis tumor suppressor gene responsible for multiple familial trichoepithelioma. J Invest Dermatol. 2004;122:658–64.
Zheng G, Hu L, Huang W, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat. 2004;23:400.
Kanitakis J, Bourchany D, Faure M, et al. Expression of the hair stem cell-specific keratin 15 in pilar tumours of skin. Eur J Dermatol. 1999;9:363–5.
Hunt SJ, Abell E. Malignant hair matrix tumor (“malignant trichoepithelioma”) arising in the setting of multiple hereditary trichoepithelioma. Am J Dermatopathol. 1991;13:275–81.
Matsuki T, Hayashi N, Mizushima J, et al. Two cases of desmoplastic trichoepithelioma. J Dermatol. 2004;31:824–7.
Jaqueti G, Requena L, Sanchez Yus E. Trichoblastoma is the most common neoplasm developed in nevus sebaceous of Jadassohn: a clinicopathologic study of a series of 155 cases. Am J Dermatopathol. 2000;22:108–18.
Regauer S, Beham-Schmid C, Okuc M, et al. Trichoblastic carcinoma (“malignant trichoblastoma”) with lymphatic and hematogenous metastases. Mod Pathol. 2000;13:673–8.
Brownstein MH, Mehregan AH, Bikowski JB, et al. The dermatopathology of Cowden’s syndrome. Br J Dermatol. 1979;100:667–73.
Hunt SJ, Kilzer B, Santa Cruz DJ. Desmoplastic trichilemmoma: histologic variant resembling invasive carcinoma. J Cutan Pathol. 1990;17:45–52.
Chan KO, Kim IJ, Baladas HG, et al. Multiple tumour presentation of trichilemmal carcinoma. Dermatol Surg. 2003;29:886–9.
Casas JG, Woscoff A. Giant pilar tumor of the scalp. Arch Dermatol. 1980;116:1395.
Fernandez SH. Malignant proliferating trichilemmal tumour: a case report. Malays J Pathol. 1999;21:117–21.
Geh JL, Moss AL. Multiple pilomatrixomata and myotonic dystrophy: a familial association. Br J Plast Surg. 1999;52:143–5.
Noguchi H, Kayashima K, Nishiyama S, et al. Two cases of pilomatrixoma in Turner’s syndrome. Dermatology. 1999;199:338–40.
Xia J, Urabe K, Moroi Y, et al. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. J Dermatol Sci. 2006;41:67–75.
Bremnes RM, Kvamme JM, Stalsberg H, et al. Pilomatrix carcinoma with multiple metastases: report of a case and review of the literature. Eur J Cancer. 1999;35:433–7.
Misago N, Mihara I, Ansai S, et al. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases. Am J Dermato pathol. 2002;24:294–304.
Bayer-Garner IB, Givens V, Smoller B. Immunohisto chemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermato pathol. 1999;21:426–31.
Sangueza OP. Hidrocistomas. Monogr Dermatol. 1993;6:146.
Boni R, Xin H, Hohl D, et al. Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol. 2001;23:87–9.
Kazakow DV, Zelger B, Rütten A, et al. Morphologic diversity of malignant neoplasms arising in pre- existing spiradenoma, cylindroma, and spyradenocylindroma based on the study of 24 cases, sporadic or occuring in the setting of Brooke-Spiegler syndrome. Am J Surg Pathol. 2009;33:705–19.
Crowson AN, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol. 2006;19:S93–S126.
Urso C, Bondi R, Paglierani M, et al. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med. 2001;125:498–505.
Akalin T, Sen S, Yuceturc A, et al. P53 protein expression in eccrine poroma and porocarcinoma. Am J Dermatopathol. 2001;23:402–6.
Waxtein L, Vega E, Cortes R, et al. Malignant nodular hidradenoma. Int J Dermatol. 1998;37:225–8.
Gerretsen AL, van der Putte SC, Deenstra W, et al. Cutaneous cylindroma with malignant transformation. Cancer. 1993;72:1618–23.
Granter SR, Seeger K, Calonje E, et al. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97–103.
Satter EK, Graham BS. Chondroid syringoma. Cutis. 2003;71:49–52.
Yamamoto O, Yasuda H. An immunohistochemical study of the apocrine type of cutaneous mixed tumors with special reference to their follicular and sebaceous differentiation. J Cutan Pathol. 1999;26:232–41.
Nather A, Sutherland IH. Malignant transformation of a benign cutaneous mixed tumour. J Hand Surg [Br]. 1986;11:139–43.
Wohlfahrt C, Ternesten A, Shalin P, et al. Cytogenetic and fluorescence in situ hybridization analysis of a microcystic adnexal carcinoma with del(6)(q23q25). Cancer Genet Cytogenet. 1997;98:106–10.
Ban M, Sugie S, Kamiya H, et al. Microcystic adnexal carcinoma with lymph node metastasis. Dermatology. 2003;207:395–7.
Duke WH, Sherrod TT, Lupton GP. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited). Am J Surg Pathol. 2000;24:775–84.
Chang SE, Ahn SJ, Choi JH, et al. Primary adenoid cystic carcinoma of skin with lung metastasis. J Am Acad Dermatol. 1999;40:640–2.
Van der Kwast TH, Vuzevski VD, Ramaekers F, et al. Primary cutaneous adenoid cystic carcinoma: case report, immunohistochemistry, and review of the literature. Br J Dermatol. 1988;118:567–77.
Requena L, Kiryu H, Ackerman AB. Neoplasms with apocrine differentiation. Philadelphia: Lippincott Williams & Wilkins; 1998.
Quereshi HS, Salama ME, Chitale D, et al. Primary cutaneous mucinous carcinoma: presence of myoepithelial cells as a clue to the cutaneous origin. Am J Dermatopathol. 2004;26:353–8.
Loane J, Kealy WF, Mulcahy G. Perianal hidradenoma papilliferum occurring in a male: a case report. Ir J Med Sci. 1998;16:726–7.
Miyamoto T, Hagari Y, Inoue S, et al. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol. 2005;58(7):757–61.
Van der Putte SC, Van Gorp LH. Adenocarcinoma of the mammary-like glands of the vulva: a concept unifying sweat gland carcinoma of the vulva, carcinoma of supernumerary mammary glands and extramammary Paget’s disease. J Cutan Pathol. 1994;21(2):157–63.
Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms-part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2007;60:145–59.
Fistarol S, Anliker M, Itin P. Cowden disease or multiple hamartoma syndrome – cutaneous clues to internal malignancy. Eur J Dermatol. 2002;12:412–21.
Salem O, Steck W. Cowden’s Disease (multiple hamartoma syndrome). A case report and review of the English literature. J Am Acad Dermatol. 1983;8:686–96. 10.
Starinck T, van der Veen J, Arwert F, et al. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet. 1986;29:222–33.
Ruhoy S, Thomas D, Nuovo G. Multiple inverted follicular keratoses as a presenting sign of Cowden’s syndrome: case report with human papillomavirus studies. J Am Acad Dermatol. 2004;51:411–5.
Pilarski R. Cowden’s syndrome: a critical review of the clinical literature. J Genet Couns. 2009;18:13–27.
Waite K, Eng C. Protean PTEN: form and function. Am J Hum Genet. 2002;70:829–44.
Eng C. PTEN: one gene, many syndromes. Hum Mutat. 2003; 22:183–98.
Squarize C, Castilho R, Gutkind J. Chemoprevention and treatment of experimental Cowden’s disease by mTOR inhibition with rapamycin. Cancer Res. 2008;68:7066–72.
Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;12:980–7.
Akhtar S, Oza K, Khan S, Wright J. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999;41:681–6.
Cohen P, Kohn S, Kurzrock R. Association of sebaceous gland and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991;90:606–13.
Kruse R, Rutten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair gene mutations similar to that in hereditary non-polyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63–70.
South C, Hampel H, Comeras I, Westman J, Frankel W, de la Chapelle A. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008;100:277–81.
Levi Z, Hazazi R, Kedar-Barnes I, et al. Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndrome. Am J Transplant. 2007;7:476–9.
Gaskin BJ, Fernando BS, Sullivan CA, et al. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome. Br J Ophthalmol. 2011;95:1686–90.
Groen E, Roos A, Muntinghe F, et al. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol. 2008;15:2439–50.
Lipton L, Tomlinson I. The genetics of FAP and FAP-like syndromes. Fam Cancer. 2006;5:221–6.
Goss K, Groden J. Biology of the adenomatous polyposis tumor suppressor gene. J Clin Oncol. 2000;18:1967–79.
Lynch PM. Chemoprevention with special reference to inherited colorectal cancer. Fam Cancer. 2008;7:59–64.
Zbar B, Alvord W, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11:393–400.
Adley B, Smith N, Nayar R, Yang X. Birt-Hogg-Dube’ syndrome. Clinicopathologic findings and genetic alterations. Arch Pathol Lab Med. 2006;130:1865–70.
Leter E, Koopmans A, Gille JJ, et al. Birt-Hogg-Dube syndrome: clinical and genetic studies of 20 families. J Invest Dermatol. 2008;128:45–9.
Toro J, Wei M, Glenn G, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube’ syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008;45:321–31.
Warren M, Torres-Cabala C, Turner ML, et al. Expression of Birt- Hogg-Dube gene mRNA in normal and neoplastic human tissues. Mod Pathol. 2004;17:998–1011.
Hartman T, Nicolas E, Klein-Szanto A, et al. The role of the Birt-Hogg-Dube’ protein in mTOR activation and renal tumorigenesis. Oncogene. 2009;28:1594–604.
Baba M, Furihata M, Hong S, et al. Kidney-targeted Birt-Hogg-Dube’gene inactivation in a mouse model: Erk1⁄2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst. 2008;100:140–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- APC
-
Adenomatous polyposis coli
- BCC
-
Basal-cell carcinoma
- BHDS
-
Birt–Hogg–Dube’ syndrome
- CAT
-
Cutaneous appendage tumors
- CHRPE
-
Congenital hypertrophy of the retinal pigment epithelium
- CS
-
Cowden syndrome
- CSG
-
Cutaneous sweat gland
- CSGT
-
Cutaneous sweat gland tumours
- FAP
-
Familial adenomatous polyposis
- FLCN
-
Folliculin
- GS
-
Gardner syndrome
- H&E
-
Haematoxylin and eosin
- MFT
-
Multiple familial tricoepithelioma
- MLG
-
Mammary-like glands
- MTS
-
Muir–Torre syndrome
- NSJ
-
Nevus sebaceous of Jadassohn
- PTC
-
Proliferating trichilemmal cyst
- PTEN
-
Phosphatase and TENsin
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Franco, R. et al. (2014). Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions. In: Baldi, A., Pasquali, P., Spugnini, E. (eds) Skin Cancer. Current Clinical Pathology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-7357-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7357-2_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-7356-5
Online ISBN: 978-1-4614-7357-2
eBook Packages: MedicineMedicine (R0)